At one time, it was a was the best-selling drug on earth.
The arthritis treatment Humira, approved by the U.S. Food & Drug Administration in 2002, racked up sales of net sales exceeding $20.7 billion in 2021 and became the big item for AbbVie (ABBV) – Get Free Report, the drug company that was spun off from Abbott Laboratories (ABT) – Get Free Report in 2013.
Stay Ahead of the Curve: Subscribe Now to Receive Instant Breaking News Alerts Directly to Your Inbox!
- Latest
- Popular
-
Braze Is Positioned To Capture Share In A Growing Market, Says Bullish Analyst
wealthreport Oct 23, 2024 -
Asian stocks are mixed following a quiet day on Wall Street
wealthreport Oct 23, 2024 -
Stock Market LIVE Updates: Sensex, Nifty likely to open lower signals GIFT Nifty; Asia markets climb
wealthreport Oct 23, 2024 -
China think tank proposes $280 billion stock market stabilisation fund
wealthreport Oct 23, 2024
-
Lululemon Athletica Inc. (LULU): Analysts Are Bullish On This Quality Stock Right Now
wealthreport Oct 6, 2024 -
Stocks Are Looking Pricey: Should You Really Buy Now?
wealthreport Oct 6, 2024 -
Knight-Swift Transportation Hol (KNX) Stock Forecasts
wealthreport Sep 26, 2024 -
Bosses are firing Gen Z grads just months after hiring them—here’s what they say needs to change
wealthreport Sep 26, 2024
SPECIAL POST
Bosses are firing Gen Z grads just months after hiring them—here’s what they say needs to change
wealthreport
Sep 26, 2024
Knight-Swift Transportation Hol (KNX) Stock Forecasts
wealthreport
Sep 26, 2024
This 6.5%-Yielding Stock Has Paid Dividends for Nearly 70 Years and Has Plenty of Fuel to Continue Paying Them
wealthreport
Sep 26, 2024